within Pharmacolibrary.Drugs.ATC.G;

model G03AB05
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 0.15 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600,            
    Vdp             = 0.0018,
    k12             = 3,
    k21             = 3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03AB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Desogestrel and ethinylestradiol is a combined oral contraceptive pill used for the prevention of pregnancy. It consists of desogestrel, a progestin, and ethinylestradiol, an estrogen. This combination is approved and widely used today for hormonal contraception.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult women following oral administration of standard contraceptive dose.</p><h4>References</h4><ol><li><p>McClamrock, HD, &amp; Adashi, EY (1993). Pharmacokinetics of desogestrel. <i>American journal of obstetrics and gynecology</i> 168(3 Pt 2) 1021–1028. DOI:<a href=\"https://doi.org/10.1016/0002-9378(93)90332-d\">10.1016/0002-9378(93)90332-d</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8447355/\">https://pubmed.ncbi.nlm.nih.gov/8447355</a></p></li><li><p>Jung-Hoffmann, C, &amp; Kuhl, H (1989). Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives. <i>Contraception</i> 40(3) 299–312. DOI:<a href=\"https://doi.org/10.1016/0010-7824(89)90094-2\">10.1016/0010-7824(89)90094-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2527727/\">https://pubmed.ncbi.nlm.nih.gov/2527727</a></p></li><li><p>Archer, DF, et al., &amp; Lammers, P (1994). Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol. <i>Fertility and sterility</i> 61(4) 645–651. DOI:<a href=\"https://doi.org/10.1016/s0015-0282(16)56640-0\">10.1016/s0015-0282(16)56640-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8150105/\">https://pubmed.ncbi.nlm.nih.gov/8150105</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03AB05;
